Notably, ferroptosis inducers can also activate the PERK-eIF2-ATF4-CHOP pathway, inducing the expression of p53-upregulated apoptosis regulator (PUMA) and participating in the ERS process (Lee et al., 2018)
However, the presence of adverse effects, including flushing, hyperuricemia, and impaired glycemic control, limits its clinical application
- Chloride
Alzheimer's disease is characterized by progressive cognitive decline associated with the accumulation of amyloid-beta plaques and neurofibrillary tangles composed of hyperphosphorylated tau protein
[1] [2] This triple-receptor mechanism distinguishes it from currently approved agents such as semaglutide (a GLP-1 agonist) or tirzepatide (a dual GIP/GLP-1 agonist)
Romagnoli GF, Naso A, Carraro G, Lidestri V (2002) Beneficial effects of L-carnitine in dialysis patients with impaired left ventricular function: an observational study